Receive Our Newsletter

Safe Therapies

Advcoacy_ SafetyMain

The bleeding disorders community uses the nation’s blood supply, and the products derived from them, to treat their disorders. Consequently, the safety of plasma-derived products and biologics used to treat bleeds remains one of our highest priorities. HFA asks all institutions serving users of biologic products and manufactures of biologics to place safety concerns ahead of cost.

HFA’s focus in this area includes following the development of:



Assisting and Advocating for the Bleeding Disorders Community